Skip to main content

Importance of vacutainer selection in forensic toxicological analysis of drugs of abuse.

Toennes SW, Kauert GF

Publication: J Anal Toxicol (2001) • Vol 25 • Page 339-43PMID: 11499888View on PubMedSuggested by: ISBER

Purpose

The purpose of this paper was to determine the effects of sodium fluoride/potassium oxalate on the stability of drugs of abuse in serum and plasma specimens.

Conclusion

On average, no differences in opiate or amphetamine levels were found between serum without anticoagulant and fluoride plasma. However, cocaine and its metabolite, benzoylecgonine, were higher in the fluoride plasma than in serum without anticoagulant and cannabinoid and the cocaine metabolite, ecgonine methylester, were lower. In spiked specimens, no differences were observed between serum without anticoagulant and fluoride plasma when blood was separated immediately following collection. In serum without anticoagulant, cocaine was converted rapidly to ecgonine methyester. 11-nor-delta-tetrahydrocannabinol-9-carboxylic acid (THCCOOH)-glucorinide was not hydrolyzed to THCCOOH when suspended in erythrocytes, but in serum without anticoagulant or fluoride plasma, THCCOOH increased over time at 25 degrees C. The increase was significantly higher in serum without anticoagulant specimens than in fluoride plasma (p<0.01).

Studies (2)

Purpose

The purpose of this study was to determine the effects of sodium fluoride/potassium oxalate on the measurement of drugs of abuse in serum and plasma specimens.

Summary of Findings

On average, no differences in opiate or amphetamine levels were found between serum without anticoagulant and fluoride plasma by immunoassay and GC-MS. However, cocaine and its metabolite, benzoylecgonine, were higher in the fluoride plasma than in serum without anticoagulant, where cocaine was not detected. In contrast, in fluoride plasma, levels of cannabinoid and the cocaine metabolite ecgonine methylester were lower than in serum without anticoagulant resulting in false negatives in 28% of cases. In spiked specimens, no differences were observed between serum without anticoagulant and fluoride plasma when blood was separated immediately following collection.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
    Normal
  • Platforms

    Small moleculeGC-MS
    Small moleculeImmunoassay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionOther drugs
    Suspected recreational drug use
    Biospecimen AcquisitionAnticoagulant
    None
    Sodium fluoride/potassium oxalate
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum